We are developing a new generation of biotechnology drugs
that act precisely within a targeted diseased tissue
Valitor, Inc. has developed novel methods of modifying therapeutic proteins to achieve substantial control over their pharmacokinetics, target specificity and bioactivity. Our technology platform can be broadly applied to improve the pharmacological properties of many protein drugs that are currently approved or under development. Our lead product will be used to improve the treatment of diseases in ophthalmology. We also have development pipelines for products in the fields of oncology and orthopedics .
Join our mailing list to get updates about Valitor, Inc.